Literature DB >> 8554127

Pancreaticoduodenectomy for benign disease.

S A Barens1, K D Lillemoe, H S Kaufman, P K Sauter, C J Yeo, M A Talamini, H A Pitt, J L Cameron.   

Abstract

BACKGROUND: Surgeons are often called upon to perform pancreaticoduodenectomy for either suspicion of malignancy or symptoms due to benign disease. Perioperative morbidity and mortality following pancreaticoduodenectomy have decreased markedly over the last 2 decades. In response, many surgical centers advocate expanding the indications for pancreaticoduodenectomy to include lesions other than periampullary carcinoma. PATIENTS AND METHODS: A retrospective review of medical records for 108 patients undergoing pancreaticoduodenectomy for benign disease at The Johns Hopkins Medical Institutions over 100 months was completed. The subset of patients with a histopathologic diagnosis of chronic pancreatitis was identified and compared with patients undergoing pancreaticoduodenectomy for other benign conditions.
RESULTS: The mortality rate for the present series was less than 1%. Perioperative complications, the majority of which were self-limited, occurred in 51% of patients. The most common complication was delayed gastric emptying. Pancreatic anastamotic leak occurred in 18% of patients and developed significantly more frequently in patients with benign diseases other than chronic pancreatitis (31% versus 8%, P < 0.05).
CONCLUSION: Among appropriately selected patients, the rates of perioperative mortality and serious morbidity are low, and concerns about mortality and morbidity should not prevent an aggressive approach to surgical resection in patients with benign disease.

Entities:  

Mesh:

Year:  1996        PMID: 8554127     DOI: 10.1016/s0002-9610(99)80087-7

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  32 in total

Review 1.  Pylorus-preserving pancreaticoduodenectomy in the treatment of chronic pancreatitis.

Authors:  Ramon E Jimenez; Carlos Fernandez-Del Castillo; David W Rattner; Andrew L Warshaw
Journal:  World J Surg       Date:  2003-10-13       Impact factor: 3.352

2.  How to pass on expertise: pancreatoduodenectomy at a teaching hospital.

Authors:  Peter Wamser; Anton Stift; Christian Passler; Peter Goetzinger; Thomas Sautner; Raimund Jakesz; Reinhold Fuegger
Journal:  World J Surg       Date:  2002-09-26       Impact factor: 3.352

3.  Does extended pancreaticoduodenectomy increase operative morbidity and mortality vs. standard pancreaticoduodenectomy?

Authors:  C Iacono; L Bortolasi; E Facci; G Falezza; G Prati; G Mangiante; G Serio
Journal:  J Gastrointest Surg       Date:  1997 Sep-Oct       Impact factor: 3.452

4.  Pancreaticoduodenectomy. Does it have a role in the palliation of pancreatic cancer?

Authors:  K D Lillemoe; J L Cameron; C J Yeo; T A Sohn; A Nakeeb; P K Sauter; R H Hruban; R A Abrams; H A Pitt
Journal:  Ann Surg       Date:  1996-06       Impact factor: 12.969

5.  Benign disease and unexpected histological findings after pancreaticoduodenectomy: the role of endoscopic ultrasound fine needle aspiration.

Authors:  Tommaso Maria Manzia; Luca Toti; Ilaria Lenci; Magdy Attia; Laura Tariciotti; Simon R Bramhall; John A C Buckels; Darius F Mirza
Journal:  Ann R Coll Surg Engl       Date:  2010-05       Impact factor: 1.891

6.  Binding versus conventional pancreaticojejunostomy after pancreaticoduodenectomy: a case-matched study.

Authors:  Léon Maggiori; Alain Sauvanet; Ganesh Nagarajan; Safi Dokmak; Béatrice Aussilhou; Jacques Belghiti
Journal:  J Gastrointest Surg       Date:  2010-06-25       Impact factor: 3.452

7.  Extended follow-up and outcomes of patients undergoing pancreaticoduodenectomy for nonmalignant disease.

Authors:  Nicholas Thomas Orfanidis; David E Loren; Carmi Santos; Eugene P Kennedy; Ali A Siddiqui; Harish Lavu; Charles J Yeo; Thomas E Kowalski
Journal:  J Gastrointest Surg       Date:  2011-11-05       Impact factor: 3.452

8.  Is intraoperative confirmation of malignancy during pancreaticoduodenectomy mandatory?

Authors:  Giuseppe Garcea; Matthew S Metcalfe; David P Berry; Gavin S Robertson; David M Lloyd; Ashley R Dennison
Journal:  J Gastrointest Surg       Date:  2011-10-28       Impact factor: 3.452

9.  Pancreaticoduodenectomy in a Latin American country: the transition to a high-volume center.

Authors:  Carlos Chan; Bernardo Franssen; Alethia Rubio; Luis Uscanga
Journal:  J Gastrointest Surg       Date:  2007-09-01       Impact factor: 3.452

10.  Cost-effectiveness of prophylactic surgery for duodenal cancer in familial adenomatous polyposis.

Authors:  Wesley H Greenblatt; Chin Hur; Amy B Knudsen; John A Evans; Daniel C Chung; G Scott Gazelle
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-09-29       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.